Filing summary
Entity-name discrepancy: The request identifies SRX Global Inc., but the supplied Form 10-Q is for Better Choice Company Inc. (NYSE American: BTTR). The summary below reflects the filing provided, for the quarter ended March 31, 2024.
Business context and reporting period
Better Choice sells pet food, treats, supplements and related products under the Halo brand through e-commerce, international, direct-to-consumer (DTC) and brick-and-mortar channels. The financial statements are unaudited and report the three months ended March 31, 2024, compared with the same 2023 period. A 1-for-44 reverse stock split took effect March 20, 2024; share and per-share figures were retroactively adjusted.
Financial performance and position
| Metric | Q1 2024 | Q1 2023 / prior date |
|---|---|---|
| Net sales | $7.903 million | $9.237 million |
| Gross profit / margin | $2.614 million / 33% | $3.241 million / 35% |
| Operating loss | $2.466 million | $3.255 million |
| Net loss | $2.830 million | $3.484 million |
| Net loss per share, basic and diluted | $3.60 | $5.03 |
| Cash used in operating activities | $1.006 million | $1.473 million |
| Cash and cash equivalents | $3.876 million | $4.455 million at Dec. 31, 2023 |
| Total assets / liabilities | $15.444 million / $14.318 million | $16.737 million / $13.759 million at Dec. 31, 2023 |
| Stockholders’ equity | $1.126 million | $2.978 million at Dec. 31, 2023 |
Current assets were $14.586 million and current liabilities $14.266 million at quarter-end, leaving approximately $0.320 million of working capital. Debt reported as current totaled $5.225 million: a $2.171 million receivables facility and $3.054 million net term loan. Interest expense was $0.362 million, versus $0.229 million a year earlier. Investing cash outflow was $0.003 million; financing provided $0.430 million. Cash declined by $0.579 million during the quarter.
Material changes versus the prior period
- Sales declined 14%, primarily due to new international payment terms intended to preserve cash and lower e-commerce traffic. Brick-and-mortar sales fell to $0.555 million from $1.709 million; international sales rose to $2.874 million from $2.311 million.
- Gross margin fell 2 percentage points to 33%. Management cited discounted sales of excess inventory, product mix and lower volume, and a higher inventory reserve associated with Halo Elevate expiration risk.
- SG&A declined 22% to $5.080 million, reflecting lower marketing, compensation and share-based compensation costs, partly offset by higher international sales commissions.
- Net loss narrowed by $0.654 million, but interest expense increased 58% to $0.362 million.
- Inventory, net, decreased to $5.201 million from $6.611 million at year-end. Accounts payable increased to $7.478 million from $6.928 million.
Outlook, risks and unusual items
- Going concern and debt covenant concern: Management states substantial doubt exists about the company’s ability to continue as a going concern for twelve months after issuance, citing recurring losses, liquidity needs and covenant issues. The filing says the Alphia debt may be callable and that additional capital, financing, lender waivers or amendments may be needed. However, the debt note also says the company was in compliance with Alphia Term Loan covenants as of March 31, 2024. This is an important inconsistency to clarify.
- The Alphia term loan carries 10% interest, compounded quarterly, and is secured by company assets, including intellectual property. The Wintrust receivables facility had an 11% rate at March 31, 2024. The filing classifies all debt as current; its maturity schedule lists $5.379 million for 2024. The exact reconciliation among carrying value, principal, PIK interest, callable status and maturity schedule is not clear from the filing text.
- Management planned to exit the DTC channel in Q2 2024 to improve profitability. It also described margin initiatives, co-manufacturer changes, pricing optimization and product innovation, but gave no quantified earnings or sales guidance.
- In February 2024, the company acquired pre-revenue Aimia Pet Healthco for approximately $0.4 million in stock to pursue pet weight-management products. The preliminary allocation recorded approximately $0.405 million of goodwill.
- On March 25, 2024, the company sued to enforce a right of first refusal exercised by Alphia concerning a proposed acquisition of Halo assets; outcome and business impact were undetermined.
- After quarter-end, the company authorized up to $5.0 million of share repurchases through December 31, 2024, while reporting going-concern doubt and limited liquidity. It also borrowed another $0.8 million from Wintrust in April and $0.6 million in May.
- In April 2024, NYSE American notified the company that it did not meet the $4.0 million stockholders’ equity continued-listing standard. Trading continued, and the company was required to submit a compliance plan by May 24, 2024, with a cure period through October 24, 2025.
- Disclosure controls and procedures were deemed ineffective at March 31, 2024 because of previously reported material weaknesses relating to complex transactions and revenue recognition; remediation remained underway. The filing also describes cybersecurity and IT general-controls remediation.
- Customer and supplier concentration is significant: three customers represented 70% of Q1 gross sales, two customers accounted for 89% of quarter-end receivables, and two vendors supplied approximately 75% of inventory purchases.
Most important facts for investors to verify
- Confirm the issuer: the supplied filing is for Better Choice Company Inc., not SRX Global Inc.
- Reconcile the Alphia covenant-compliance statements, callable-debt disclosure, current classification and stated 2024 maturity amount.
- Assess near-term liquidity, lender remedies, borrowing availability and the feasibility of required financing or covenant relief.
- Review the rationale and funding for the $5.0 million repurchase authorization given cash levels and the going-concern warning.
- Track NYSE American compliance-plan status and the consequences if the company does not regain compliance.
- Monitor DTC exit execution, inventory aging and reserves, channel/customer concentration, and remediation of control weaknesses.